Investing.com - Zimmer Biomet reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Zimmer Biomet announced earnings per share of $1.9 on revenue of $2.03B. Analysts polled by Investing.com anticipated EPS of $1.86 on revenue of $1.97B.
Zimmer Biomet shares are up 5% from the beginning of the year, still down 9.62% from its 52 week high of $180.36 set on April 29. They are under-performing the S&P 500 which is up 16.8% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar